Monthly Archives: October 2012

Parkinsonism

Comments are closed

October 31, 2020 at 11:11 am , by Synergy Health

Parkinsonism causes the same symptoms as Parkinson’s disease, but is not Parkinson’s disease. However, it requires coping mechanisms, too. First, a little about Parkinsonism. Parkinsonism is a condition that results in the same movement disorders as Parkinson’s disease. Some people with Parkinsonism do have Parkinson’s disease, but other causes exist

Who Gets Parkinson’s

Comments are closed

October 31, 2020 at 10:53 am , by Synergy Health

Parkinson’s disease affects men and women equally, an unusual characteristic for a chronic disease. Furthermore, ethnicity and socio-economic backgrounds show no apparent influence, either. However, age factors in significantly, with most patients being 65 or older. About one percent of the elderly show some form of the disease. The National

Sharing Hallucinations

Comments are closed

October 31, 2020 at 10:35 am , by Synergy Health

“A spider on the wall said hello to me.” In the 1960′s, neurologist Oliver Sacks took a drug called arcane, which is used sometimes in the treatment of Parkinson’s. But he didn’t stop there. And now, Sacks has collected all of his hallucination experiences into a book aptly titled Hallucinations.

Researchers Accelerate Bacterial Genes Search in Lyme

Comments are closed

October 31, 2020 at 10:18 am , by Synergy Health

Bacterial genes may make Lyme disease persistent and strong, so researchers from The University of Texas Health Science Center at Houston (UTHealth) have sped up their search for them via a new technique. If they discover the genes, it could lead to new treatments, giving hope to the 30,000 Americans

Bring It On!

Comments are closed

October 31, 2020 at 9:58 am , by Synergy Health

In this piece, a man living with multiple sclerosis discusses how he faces challenges like MS and Hurricane Sandy. Stress affects MS, and facing a hurricane when living near the Maine coastline ranks up there as more than stressful. But people have the ability to forge ahead, as the author

Lyme Disease: A Must See

Comments are closed

October 31, 2020 at 9:52 am , by Synergy Health

This video explains Lyme, and talks about one woman’s devastation from the disease via a young man whose good friend suffers from Lyme. Anyone who suffers from Lyme might seriously think about sharing this video with people they know who need more information on it. The video also covers the

23rd International ALS Symposium in December

Comments are closed

October 31, 2020 at 9:44 am , by Synergy Health

This December 2-7, the 20th Annual Meeting International Alliance of ALS/MND Associations and 23rd International Symposium on ALS/MND will be held in in Chicago. According to the alliance’s website, “Motor Neurone Disease (MND) is an all embracing term used to cover a number of illnesses of the motor neurone. Amyotrophic

RNA Enzyme: Potential Therapeutic Target

Comments are closed

October 30, 2020 at 1:36 pm , by Synergy Health

The ALS Association partially funded a new study which reveals the possibility of a new target drug to treat amyotrophic lateral sclerosis (ALS) or Lou Gehrig’s Disease. Protein clumps that gather within motor neurons are believed to be toxic to those neurons. The protein is called TDP-43. Lowering the levels

Possibility of Gender Influence in MS

Comments are closed

October 30, 2020 at 1:28 pm , by Synergy Health

Recovery from optic neuritis (ON) may depend more on gender influences than previously thought. This was determined in a study that measured the retinal nerve fiber layer (RNFL) differences in men and women six months after an ON occurrence. In this study, more men (62%) than women (41%) had a

Myelin Repair Foundation Annual Meeting

Comments are closed

October 30, 2020 at 1:08 pm , by Synergy Health

The entire team of researchers from the Myelin Repair Foundation gathered at their annual research meeting to plan how to move forward in the myeline repair clinical trials. That team consists of clinical cell biologists, genetics specialists, government experts, immunologists, MRF scientific staff members, and neurologists. The topics of discussion